XML 202 R43.htm IDEA: XBRL DOCUMENT v3.25.1
Measurement of financial assets and liabilities (Tables)
12 Months Ended
Dec. 31, 2024
Financial instruments  
Schedule of financial assets and liabilities by IFRS 9 category

Financial instruments

Classification under IFRS 9

Financial assets

Loans

Amortised cost (31 Dec 2024: $153 million; 31 Dec 2023: $148 million)

Mandatorily at FVTPL (31 Dec 2024: $364 million; 31 Dec 2023: $430 million)

Equity securities and portfolio holdings in collective investment schemes

Mandatorily at FVTPL

Debt securities

Mandatorily at FVTPL

Derivative assets

Mandatorily at FVTPL

Accrued investment income

Amortised cost

Deposits

Amortised cost

Cash and cash equivalents

Amortised cost

Other debtors

Amortised cost

Financial liabilities

Investment contract liabilities without DPF

Mandatorily at FVTPL

Derivative liabilities

Mandatorily at FVTPL

Core structural borrowings of shareholder-financed businesses

Amortised cost

Operational borrowings

Amortised cost

Obligations under funding, securities lending and sale and repurchase agreements

Amortised cost

Net asset value attributable to unit holders of consolidated investment funds note

Designated at FVTPL

Other liabilities

Amortised cost

Schedule of contractual maturities of financial liabilities, excluding derivative liabilities, on an undiscounted cash flow basis

31 Dec 2024 $m

Contractual maturity profile for financial liabilities

Total

Total

carrying

1 year

10-15

15-20

Over

No stated

undiscounted

    

value

    

or less

    

1-2 years

    

2-5 years

    

5-10 years

    

years

    

years

    

20 years

    

maturity

    

cash flows

Investment contracts without DPF note

748

186

9

69

114

19

7

4

360

768

Core structural borrowings of shareholder-financed businesses

 

3,925

125

125

678

3,111

750

4,789

Lease liabilities under IFRS 16

257

84

71

111

18

284

Other operational borrowings

 

540

540

540

Obligations under funding, securities lending and sale and repurchase agreements

 

272

272

272

Accruals, deferred income and other liabilities

 

2,848

2,641

265

2,906

Net asset value attributable to unit holders of consolidated investment funds

 

2,679

2,679

2,679

Total non-derivative financial liabilities

11,269

6,527

205

858

3,243

19

7

4

1,375

12,238

31 Dec 2023 $m

Contractual maturity profile for financial liabilities

Total

Total

carrying

1 year

10-15

15-20

Over

No stated

undiscounted

    

value

    

or less

    

1-2 years

    

2-5 years

    

5-10 years

    

years

    

years

    

20 years

    

maturity

    

cash flows

Investment contracts without DPF note

769

155

169

68

149

24

9

5

273

852

Core structural borrowings of shareholder-financed businesses

 

3,933

 

126

 

126

379

 

3,555

 

 

 

 

750

 

4,936

Lease liabilities under IFRS 16

234

76

62

86

25

2

251

Other operational borrowings

 

707

 

707

 

 

 

 

 

 

 

707

Obligations under funding, securities lending and sale and repurchase agreements

 

716

 

716

 

 

 

 

 

 

 

716

Accruals, deferred income and other liabilities

 

4,035

 

3,845

 

 

 

 

 

 

190

 

4,035

Net asset value attributable to unit holders of consolidated investment funds

 

2,711

 

2,711

 

 

 

 

 

 

 

2,711

Total non-derivative financial liabilities

 

13,105

 

8,336

 

357

533

 

3,729

 

26

 

9

 

5

 

1,213

 

14,208

Schedule of maturity profile of net derivative positions

Carrying value of net derivatives $m

Net

Derivative

Derivative

derivative

    

assets

    

liabilities

    

position

31 Dec 2024

 

395

(1,617)

(1,222)

31 Dec 2023

 

1,855

(238)

1,617

Schedule of gross and net information about financial instruments subject to master netting arrangements

31 Dec 2024 $m

Related amounts not offset

Gross amount

in the balance sheet

    

included in the

    

    

    

    

Net amount

balance

Financial

Cash

Securities

included in the

sheet

instruments

collateral

collateral

balance sheet

note (i)

note (ii)

note (iii)

note (iv)

Derivative assets

 

376

(106)

(267)

3

Reverse repurchase agreements

 

2,868

(2,868)

Total financial assets

 

3,244

(106)

(267)

(2,868)

3

Derivative liabilities

 

(1,597)

106

512

927

(52)

Securities lending and repurchase agreements

 

(272)

43

228

(1)

Total financial liabilities

 

(1,869)

106

555

1,155

(53)

31 Dec 2023 $m

Related amounts not offset

Gross amount

in the balance sheet

    

included in the

    

    

    

    

Net amount

balance

Financial

Cash

Securities

included in the

sheet

instruments

collateral

collateral

balance sheet

note (i)

note (ii)

note (iii)

note (iv)

Derivative assets

 

1,820

 

(138)

 

(1,529)

(11)

 

142

Reverse repurchase agreements

 

3,616

 

(12)

 

 

(3,604)

 

Total financial assets

 

5,436

 

(150)

 

(1,529)

 

(3,615)

 

142

Derivative liabilities

 

(225)

 

138

 

57

 

 

(30)

Securities lending and repurchase agreements

 

(713)

 

 

(18)

 

730

 

(1)

Total financial liabilities

 

(938)

 

138

 

39

 

730

 

(31)

Notes

(i)

The Group has not offset any of the amounts included in the balance sheet.

(ii)

Represents the amount that could be offset under master netting or similar arrangements where the Group does not satisfy the full criteria to offset in the balance sheet.

(iii)

Excludes initial margin amounts for exchange-traded derivatives.

(iv)

In the tables above, the amounts of assets or liabilities included in the balance sheet would be offset first by financial instruments that have the right of offset under master netting or similar arrangements with any remaining amount reduced by the amount of cash and securities collateral. The actual amount of collateral may be greater than amounts presented in the tables.

At fair value  
Financial instruments  
Schedule of fair value of assets and liabilities

31 Dec 2024 $m

 

Level 1

Level 2

Level 3

 

    

Quoted prices

Valuation based

Valuation based

 

(unadjusted)

on significant

on significant

 

in active

observable

unobservable

 

      

markets

      

market inputs

      

market inputs

      

Total

 

    

    

    

note (iii)

    

    

Loans

 

364

364

Equity securities and holdings in collective investment schemes

 

72,574

5,311

3,117

81,002

Debt securities note (i)

 

56,147

17,620

37

73,804

Derivative assets

 

17

378

395

Derivative liabilities

 

(493)

(1,124)

(1,617)

Total financial investments, net of derivative liabilities

 

128,245

22,549

3,154

153,948

Investment contract liabilities without DPFnote (ii)

 

(748)

(748)

Net asset value attributable to unit holders of consolidated investment funds

 

(2,679)

(2,679)

Total financial instruments at fair value

 

125,566

21,801

3,154

150,521

Percentage of total (%)

83

%

15

%

2

%

100

%

31 Dec 2023 $m

 

Level 1

Level 2

Level 3

 

Quoted prices

Valuation based

Valuation based

 

(unadjusted)

on significant

on significant

 

in active

observable

unobservable

 

      

markets

      

market inputs

      

market inputs

      

Total

 

    

    

    

note (iii)

    

    

Loans

 

430

 

 

430

Equity securities and holdings in collective investment schemes

 

56,327

5,562

 

2,864

 

64,753

Debt securities note (i)

 

64,004

19,020

 

40

 

83,064

Derivative assets

 

1,460

395

 

 

1,855

Derivative liabilities

 

(58)

(180)

 

 

(238)

Total financial investments, net of derivative liabilities

 

121,733

25,227

 

2,904

 

149,864

Investment contract liabilities without DPFnote (ii)

 

(769)

 

 

(769)

 

Net asset value attributable to unit holders of consolidated investment funds

 

(2,711)

 

 

(2,711)

 

Total financial instruments at fair value

 

119,022

24,458

 

2,904

 

146,384

 

Percentage of total (%)

81

%

17

%

2

%

100

%

Notes

(i)

Of the total level 2 debt securities of $17,620 million at 31 December 2024 (31 December 2023: $19,020 million), $12 million (31 December 2023: $10 million) are valued internally.

(ii)

For Investment contract liabilities without DPF, it is assumed that these investment contracts are not quoted in an active market and do not have readily available published prices and that their fair values are determined using valuation techniques. It is assumed that all significant inputs used in the valuation are observable and these investment contract liabilities are classified in level 2.

(iii)

At 31 December 2024, the Group held $3,154 million (31 December 2023: $2,904 million) of net financial instruments at fair value within level 3. This represents 2 per cent (31 December 2023: 2 per cent) of the total fair valued financial assets, net of financial liabilities and comprises the following:

Equity securities and holdings in collective investment schemes of $3,116 million (31 December 2023: $2,863 million) consisting primarily of property, infrastructure, private credit and private equity funds held by the participating funds, which are externally valued using the net asset value of the invested entities. Equity securities of $1 million (31 December 2023: $1 million ) are internally valued, representing less than 0.1 per cent of the total fair valued financial assets, net of financial liabilities. Internal valuations are inherently more subjective than external valuations; and

Other sundry individual financial instruments of a net asset of $37 million(31 December 2023: $40 million).

Of the net financial instruments of $3,154 million (31 December 2023: $2,904 million) referred to above:

A net asset of $3,088 million (31 December 2023: $2,866 million) is held by the Group’s participating and unit-linked funds and therefore shareholders’ profit and equity are not immediately impacted by movements in the valuation of these financial instruments; and

The remaining level 3 investments comprise a net asset of $66 million (31 December 2023: $38 million) and are primarily investments valued using external prices adjusted to reflect the specific known conditions relating to these holdings where applicable (eg distressed securities). If the value of all these level 3 financial instruments decreased by 10 per cent, the change in valuation would be $(7) million (31 December 2023: $(4) million), which would reduce shareholders’ equity by this amount before tax.

Schedule of reconciliation of movements in level 3 financial instruments measured at fair value

2024 $m

Equity

securities

and holdings

in collective

investment

Debt

    

Loans

    

schemes

    

securities

    

Group total

Balance at 1 Jan

 

2,864

40

2,904

Total gain (loss) in income statement note

 

(84)

3

(81)

Total loss recorded in other comprehensive income

 

 

(31)

 

(1)

 

(32)

Purchases and other additions

462

2

464

Sales

(94)

(7)

(101)

Balance at 31 Dec

 

 

3,117

 

37

 

3,154

2023 $m

Equity

securities

and holdings

in collective

investment

Debt

    

Loans

    

schemes

    

securities

    

Group total

Balance at 1 Jan

 

3

 

824

 

38

 

865

Total gains in income statement note

 

 

25

 

2

 

27

Total gains recorded in other comprehensive income

 

 

6

 

 

6

Purchases and other additions

 

 

524

 

 

524

Sales

 

(3)

 

(4)

 

 

(7)

Transfers into level 3

 

 

1,489

 

 

1,489

Balance at 31 Dec

 

 

2,864

 

40

 

2,904

Note

Of the total net (loss) gain in the income statement of $(81) million at 2024 (2023: $27 million), $(143) million (2023: $29 million) relates to net unrealised gain (loss) of financial instruments still held at the end of the year, which can be analysed as follows:

    

2024 $m

    

2023 $m

Equity securities and holdings in collective investment schemes

 

(146)

 

27

Debt securities

 

3

 

2

Net unrealised (loss) gains of financial instruments still held at the end of the year

 

(143)

 

29

Schedule of net unrealised gains and losses in the income statement for financial instruments still held at the end of the year

    

2024 $m

    

2023 $m

Equity securities and holdings in collective investment schemes

 

(146)

 

27

Debt securities

 

3

 

2

Net unrealised (loss) gains of financial instruments still held at the end of the year

 

(143)

 

29

Assets and liabilities at amortised cost for which fair value is disclosed  
Financial instruments  
Schedule of fair value of assets and liabilities

    

31 Dec 2024 $m

    

31 Dec 2023 $m

Carrying

Fair

Carrying

Fair

value

value

value

value

    

    

note (iii)

    

    

note(iii)

Financial assets

Loans note (i)

 

153

163

 

148

179

Financial liabilities

Core structural borrowings of shareholder-financed businesses note (ii)

 

(3,925)

(3,694)

 

(3,933)

(3,659)

Operational borrowings (excluding lease liabilities) note (i)

 

(540)

(540)

 

(707)

(707)

Obligations under funding, securities lending and sale and repurchase agreements note (i)

 

(272)

(272)

 

(716)

(716)

Net financial liabilities at amortised cost

(4,584)

(4,343)

(5,208)

(4,903)